See Tijms and Teunissen (doi:10.1093/brain/awaa422) for a scientific commentary on this article. Plasma phosphorylated tau181 may be an accessible and scalable biomarker for Alzheimer’s disease. Moscoso et al. examine the… Click to show full abstract
See Tijms and Teunissen (doi:10.1093/brain/awaa422) for a scientific commentary on this article. Plasma phosphorylated tau181 may be an accessible and scalable biomarker for Alzheimer’s disease. Moscoso et al. examine the time course of changes in phosphorylated tau181 across the disease spectrum compared to other key biomarkers, and establish the sequence of pathological events associated with those changes.
               
Click one of the above tabs to view related content.